ARTICLE SUMMARY: Companies are being offered a new remedy by FDA when they feel the agency has gone too far in its 510(k) requests.
Regulatory & Reimbursement 2017 Regulatory Data Shows a Friendlier FDA 2017-11-27 00:00:00.0 Wendy Diller
Regulatory & Reimbursement Jeff Shuren, 10 Years in at CDRH, Wants More Space to Innovate 2019-06-27 00:00:00.0 David Filmore
Executive Interviews Expert Perspective: The Community Blog Checks In with Jeffrey Shuren 2018-10-16 00:00:00.0 Tracy Schaaf